STAT+: Pharmalittle: AstraZeneca plans to ‘love’ China’s Communist Party; U.S. Supreme Court rules against Amgen in patent case
And so, another working week will soon draw to a close. Not a moment too…
Author: STAT
After decades of neglecting women athletes, sport and exercise medicine is finally catching up
When cyclist Alison Tetrick joined the sport’s professional ranks, she received the perks that come…
Opinion: Chelsea Clinton: How to eliminate viral hepatitis by 2030
Viral hepatitis affects almost 400 million people and kills more than 1 million each year….
Opinion: How I helped Pfizer think through the ethics of Viagra 25 years ago
Twenty-five years ago, 75-year-old Bob Dole — former Republican presidential candidate and U.S. senator from…
Gene therapy death not caused by CRISPR, investigators confirm
Terry Horgan, the 27-year-old patient who died eight days after receiving a CRISPR therapy custom-built…
FDA advisory panel backs Pfizer’s RSV vaccine, but expresses some safety concerns
A committee of vaccine experts voted to recommend the Food and Drug Administration approve Pfizer’s…
Listen: The FTC v. Amgen, Sarepta’s future, & Galapagos’ turnaround
Does the FTC have it out for pharma? What does it take to make an…
Soft, stretchable electronic skin could reconstruct the sense of touch
The largest organ in the body is a wonder. Skin is soft, flexible, and sensitive…
After new cluster, health officials warn mpox could resurge this summer
Federal health officials warned Thursday that there was a significant risk the mpox virus will…
STAT+: Supreme Court rules against Amgen in closely watched case over scope of patent claims
In a case that had the pharmaceutical industry on edge, the U.S. Supreme Court upheld…
STAT+: New Biden science agency ARPA-H launches first program, targeting bone regrowth
WASHINGTON — A multibillion-dollar science agency tasked with slashing through research bureaucracy will start its…
STAT+: Pharmalittle: Appellate judges appear skeptical of FDA decisions on abortion pill; FTC widens probe into PBMs
Top of the morning to you, and a fine one it is. Once again, crystal…
Opinion: How Tennessee is creating new opportunities for doctors trained outside the U.S.
This legislative session, Gov. Bill Lee made history by signing a bill that makes Tennessee…
Opinion: One simple fix for the primary care shortage: assistant physicians
A recent study by the Association of American Medical Colleges projects a shortage of between 17,800…
STAT+: In Belgium, a native son returns to resurrect the drugmaker Galapagos — and ‘to get the trust back’
There is, according to Wall Street, no worse investment in biotech than Galapagos NV. The…
Biden drug czar: ‘All options are on the table’ for expanding methadone access
WASHINGTON — The federal government is aggressively exploring ways to increase access to methadone, a…
Opinion: Fix the rural physician shortage by expanding support for resident training
As the deans of the two public medical schools in Nevada, we are watching with…
STAT+: FTC widens probe into pharmacy benefit managers to include group purchasing organizations
The Federal Trade Commission is widening its probe into pharmacy benefit managers and their impact…
Senators probing largest Medicare Advantage plans over how algorithms factor in care denials
Senators warned the country’s largest Medicare Advantage insurers at a hearing on Wednesday that they…
Study: Giving an antibiotic to household contacts of people with leprosy slashes chances of spread
When someone has leprosy, people who live in the same household face the highest odds…
STAT+: House panel takes first steps toward reining in hospitals with ‘site-neutral’ changes
WASHINGTON — A key House panel on Wednesday advanced several health care bills on Wednesday,…
Federal judges question FDA authority in abortion pill hearing
A federal appeals court heard opening arguments Wednesday in a case that could determine the…
STAT+: Could an upcoming Supreme Court case make the FDA slower?
WASHINGTON — The Food and Drug Administration could take longer to write regulations and make…
STAT+: CVS Health to close clinical trial unit two years after launch
WOONSOCKET, R.I. — Two years after its launch, CVS Health is planning to close down…
STAT+: Pharmalittle: FTC suit over Amgen spotlights ‘bundling’ deals with insurers; FDA staff says Pfizer RSV vaccine is effective
Rise and shine, everyone. The middle of the week is upon us. Have heart, though….
STAT+: PTC Therapeutics’s PKU drug succeeds in trial, but bigger hurdles for company are ahead
Biotech firm PTC Therapeutics said Wednesday that its drug for phenylketonuria, or PKU, met its…
STAT+: A new startup looks to turn the workhorse of gene therapy against cancer
In 1980, Life and Time magazines introduced America to a new cancer wonder drug: interferon,…
Opinion: How ‘Lessons From the Covid War’ falls short
The stream of books about the government response to the pandemic that began with Michael…
Opinion: Do chatbots have more time to be empathetic than physicians?
As an oncologist, Jennifer Lycette gets to know her patients particularly well. She’s doubtful that…
Opinion: New draft recommendations for mammograms take a one-size-fits-all approach
On May 9, the United States Preventive Services Task Force (USPSTF) released updated draft recommendations…
Opinion: Starting breast cancer screening at 40 saved my life
In 2015, the year I turned 40, the American Cancer Society updated its guidelines for…
STAT+: Biotech and pharma execs wrestle with the ‘nightmare’ of developing digital biomarkers
TARRYTOWN, N.Y. — As post-lunch drowsiness settled on an auditorium full of leaders from the…
Depression hits new high among Americans, per survey
WASHINGTON — More than a quarter of American adults are depressed, a 10% surge from…
STAT+: FTC move to block the Amgen-Horizon deal highlights concerns over negotiations with insurers
In an unexpected move, the U.S. Federal Trade Commission on Tuesday filed a lawsuit to…
STAT+: AI leaders issue a plea to Congress: Regulate us, and quickly
During an extraordinary hearing Tuesday, members of a Senate subcommittee called for aggressive regulation of…
Pfizer RSV vaccine seen as effective against severe disease, FDA documents say
An experimental RSV vaccine developed by Pfizer to protect infants — by vaccinating pregnant people…
Telehealth company Included Health ventures into home care
You’re reading the web edition of STAT Health Tech, our guide to how tech is…
Test – STAT+ Only virtual event
Opportunities to engage with STAT reporters and leading industry experts Join the conversation! STAT+ subscribers…
STAT+: FTC files lawsuit to block Amgen’s purchase of Horizon Therapeutics
The Federal Trade Commission on Tuesday sued to block Amgen’s $27.8 billion acquisition of Horizon…
‘We’re failing to make progress’: Studies show ongoing toll of premature Black deaths
In the last two decades, Black Americans have suffered 1.63 million excess deaths and lost…
AstraZeneca is third member to leave PhRMA in five months
WASHINGTON — AstraZeneca has decided to leave the brand drug lobbying powerhouse PhRMA halfway through…
STAT+: Pharmalittle: FTC may sue to block Amgen deal for Horizon; Supreme Court declines Teva appeal on skinny labeling
Oh, what a beautiful morning! Pardon the cliché, but crystal clear blue skies and deliciously…
STAT+: General Catalyst, Andreessen Horowitz bet on large language models for health care
OAKLAND, Calif. — In a rare partnership, heavyweight tech venture firms General Catalyst and Andreessen…
STAT+: Boundless Bio tests a cancer drug targeting once-mysterious DNA loops
SAN DIEGO — Peering through a microscope more than a half century ago, researchers made…
Opinion: The U.S. needs to pressure India to improve drug safety
On Feb. 2, the Food & Drug Administration issued an alert warning about “Made in…
STAT+: Ketamine clinics’ bust serves as warning of business challenge facing psychedelic therapy
A chain of luxury ketamine clinics called Field Trip started churning through business strategies at…
Opinion: A breakthrough drug will require big changes for eye care doctors
Advancement in the science of eye care over the past 10 years has led to…
STAT+: Biden drug czar to summon naloxone makers to White House to discuss pricing
WASHINGTON — The White House is summoning naloxone manufacturers for a roundtable focused on the…
STAT+: Envision Healthcare files for bankruptcy
Physician staffing firm Envision Healthcare officially filed for Chapter 11 bankruptcy on Monday, a move…
STAT+: U.S. Supreme Court declines to hear ‘skinny labeling’ case with implications for generic drug access
After months of anticipation, the U.S. Supreme Court declined to hear an appeal of a…